TERRY NEVILLE: Open Payments
NPI 1457336083 · FORT GEORGE G MEADE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,639 in 118 payments from 12 companies in 2025. Trend: 2023 $842 · 2024 $1,265 · 2025 $2,639
Food & beverage: $2,615Education: $24
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 17 | $502 |
| Lundbeck LLC | 20 | $408 |
| Janssen Pharmaceuticals, Inc | 10 | $368 |
| Neurocrine BioSciences, Inc. | 10 | $279 |
| Alkermes, Inc. | 21 | $249 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $198 |
| ABBVIE INC. | 8 | $183 |
| Teva Pharmaceuticals USA, Inc. | 9 | $156 |
| Axsome Therapeutics, Inc. | 5 | $109 |
| E.R. Squibb & Sons, L.L.C. | 4 | $86 |
Products named: INVEGA SUSTENNA, FANAPT, INGREZZA, ABILIFY ASIMTUFII, ARISTADA, CAPLYTA, HETLIOZ, VRAYLAR.
Industry payments across MD — which companies pay providers there.
